Skip to main content
Cytophage Technologies Ltd. logo

Cytophage Technologies Ltd. — Investor Relations & Filings

Ticker · CYTO ISIN · CA2328211081 LEI · 254900L9XZT97QIBN831 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2025-05-30 Regulatory Filings
Country CA Canada
Listing TSXV CYTO

About Cytophage Technologies Ltd.

https://cytophage.com/

Cytophage Technologies Ltd. is a pioneering biotechnology company focused on developing synthetic bacteriophage products to prevent and treat bacterial infections, aiming to reduce and ultimately replace the use of conventional antibiotics. The company utilizes molecular genetic techniques and proprietary synthetic biology technology to create tailor-made, highly effective phages that are harmless to humans and animals. Cytophage's solutions address three primary markets: Animal Health (e.g., livestock illness prevention and growth enhancement), Food Safety (preventing disease spread without antibiotics), and Human Health (treating bacterial illnesses and hospital decontamination). A key competitive advantage is the rapid production timeline for targeted phages, enabling quick response to bacterial threats. The company is also engaged in advanced research, including the development of genetically engineered phage-based vaccines.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV2—a CEO certification of interim filings (interim financial report and MD&A) under Canadian NI 52-109. It is neither the interim report itself (IR) nor an announcement of a report (RPA), nor does it fit any more specific category (e.g., management change, dividend, transcript, etc.). It is a regulatory certificate filed with securities regulators, so the appropriate classification is the fallback “Regulatory Filings” (RNS).
2025-05-30 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for Ramp Metals Inc. for the nine-month period ended March 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Shareholders' Equity, and Statement of Cash Flows) along with detailed explanatory notes. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-05-30 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing regulatory approval (the Canadian New Substance Notification for its phage therapy candidate). It does not present financial results (not an earnings release or interim report), does not announce dividends, management changes, share issuances, or an AGM/EGM vote, nor is it a formal financial report or presentation. It is not a report publication announcement of an attached annual or interim report. Therefore, it falls under the fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2025-05-08 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of Annual Filings” by the CFO of a Canadian venture issuer, certifying the review of annual AIF, financial statements, and MD&A under NI 52-109. It is a compliance certificate accompanying annual filings, not the actual Annual Report (10-K/AR), not an audit opinion, and not any other specific category. Therefore it is a general regulatory filing.
2025-04-30 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of Annual Filings – Venture Issuer Basic Certificate” signed by the CEO. It is a statutory certification under Canadian NI 52-109, not the annual report itself, an earnings release, or any other specific category. It is a regulatory compliance filing that does not fit the specialized categories, so it defaults to the general Regulatory Filings category (RNS).
2025-04-30 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Canada’s Form 13-501F1 “Class 1 and Class 3B Reporting Issuers – Participation Fee Management Certification” filed with the Alberta Securities Commission. It is a regulatory submission detailing market value calculations and fees, not a corporate annual report, earnings release, or management commentary. It does not fit any of the specific categories like annual report, interim report, governance statement, or financing update. Therefore it falls under the fallback “Regulatory Filings” category.
2025-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.